The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II single-arm pilot study of second-line icotinib treatment in advanced esophageal cancer with EGFR over-expression or amplification.
 
Jing Huang
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Ping Lu
No Relationships to Disclose
 
Jianming Ying
No Relationships to Disclose
 
Changwu Ma
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Junfeng Liu
No Relationships to Disclose
 
Ying Liu
No Relationships to Disclose
 
Fenlai Tan
Employment - Betta Pharmaceuticals
Leadership - Betta Pharmaceuticals
Stock and Other Ownership Interests - Betta Pharmaceuticals
Honoraria - Betta Pharmaceuticals
Travel, Accommodations, Expenses - Betta Pharmaceuticals
 
Yan Sun
No Relationships to Disclose